Delivery Order SPE2DB20D6037-SPE2DB22FD0EC
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,393.26 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,558,189,631 units of Naloxone HCL 4 mg nasal spray. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,305,475 units of Naloxone Hydrochloride Nasal Spray. The delivery order is valued at $1,922.19 and will be completed by January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency to provide various pharmaceutical and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,084.80 contract is for the delivery of 4,567,311,856 units of Naloxone HCl 4 mg Nasal Spray, a critical opioid overdose reversal medication, with a period of performance through February 20, 2025. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,840.00 contract is for the delivery of 4,557,523,711 units of Naloxone Hydrochloride 4 mg Nasal Spray. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for Narcan (naloxone hydrochloride) 4 milligram nasal spray, with a total potential value of $5,526.00 and a completion date of January 22, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide various pharmaceutical and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4557384457 NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $3,420.00. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 4562900589 - NALOXONE 2 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $1,529.30 and a period of performance through November 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain program, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,434.00, is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group...
- This firm-fixed-price delivery order, valued at $2,473.12, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of Naloxone Hydrochloride Injection 0.4 mg/mL, 1 mL, to support the recurring medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $7,333.20 and provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FD0ECDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,557,954,905 units of Naloxone hydrochloride 4 mg nasal spray. The contract has a ceiling value of $5,266.28 and an ultimate completion date of August 2, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC does not have a set-aside designation, allowing DMS Pharmaceutical Group, with its woman-owned small business status, to secure direct awards for pharmaceutical Prime Vendor programs supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/1/22 |